---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000039"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:50:12.421111+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q1 adj EPS $12.58 beats; raises FY2026 adj EPS guidance to at least $26.75

## Summary
- Q1 operating revenue $49.5B (+1.5% YoY); diluted EPS $8.00, adjusted diluted EPS $12.58 (includes ~$1 non-recurring investment income).
- Health Benefits segment revenue $42.5B (+2.6% YoY); operating margin 5.1% vs 5.4% YoY.
- Carelon segment revenue $18.0B (+7.9% YoY); operating margin 5.9% vs 6.6% YoY.
- Recorded $935M accrual for CMS matter and $129M business optimization charge; adjusted operating margin 6.5%.
- FY2026 adjusted EPS guidance raised to at least $26.75; reaffirm operating cash flow at least $5.5B.

## SEC filing metadata
- accession: 0001156039-26-000039
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000039/0001156039-26-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000039/elv-20260422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000039
- JSON: https://secwatch.observer/filing/0001156039-26-000039.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000039.txt

## Key facts
- Earnings Releases
  Elevance Health, Inc. reported FY 2026 results: EPS at least $26.75. Guidance raised.
  - Period: FY 2026
  - EPS: at least $26.75
  - Guidance: raised
  - Result: guidance update
  source text: FY 2026 adjusted diluted EPS 2 guidance raised to at least $26.75, supported by underlying business strength, actions to reduce medical costs, and increased visibility
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000039/0001156039-26-000039-index.htm
- Earnings Releases
  Elevance Health, Inc. reported first quarter 2026 results: revenue $49.5 billion, EPS $8.00. Guidance raised.
  - Period: first quarter 2026
  - Revenue: $49.5 billion
  - EPS: $8.00
  - Guidance: raised
  - Result: reported results
  source text: ELEVANCE HEALTH REPORTS FIRST QUARTER 2026 RESULTS; RAISES FULL-YEAR GUIDANCE • 1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 • 1Q 2026 diluted EPS 1 of $8.00; adjusted diluted EPS 2 of $12.58 driven by strong operating results and ~$1 per share of non-recurring investment income
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000039/0001156039-26-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.